Td Vaccine launched at Central Research
Institute, Kasauli
¨
Td Vaccine launched at
Central Research Institute, Kasauli.
¨
On 21 February 2026, the
Tetanus and Adult Diphtheria (Td) vaccine launched at the Central Research
Institute, Kasauli by Union Health Minister J. P. Nadda.
¨
The Td vaccine (Tetanus
and adult Diphtheria Vaccine – Adsorbed, Reduced D-Antigen Content) provides
protection against both tetanus and diphtheria.
¨ In 2006, the World Health
Organization (WHO) recommended that countries transition from tetanus toxoid
(TT) vaccine to Td vaccine.
¨
This recommendation was
reaffirmed in the WHO Tetanus Vaccine Position Paper (2017) and in the 2002 and
2016 Strategic Advisory Group of Experts (SAGE) consultations.
¨
It was noted that
immunity against diphtheria may decline over time, making booster-based Td
vaccination necessary.
¨
The National Technical
Advisory Group on Immunization also recommended replacing TT with Td in India’s
immunization programme, including for pregnant women.
¨
The Central Research
Institute completed developmental studies, licensing processes and commercial
manufacturing preparations for the vaccine.
¨
The vaccine has received
clearance from the Central Drugs Laboratory and is ready for supply under the
Universal Immunization Programme.
¨
Following the launch,
about 55 lakh Td vaccine doses are planned to be supplied to the programme by
April 2026.
¨
The Td vaccine combines
purified diphtheria and tetanus toxoids adsorbed on aluminium phosphate with
thiomersal as preservative.
¨
Its introduction is
expected to reduce morbidity and mortality from these vaccine-preventable
diseases while strengthening India’s domestic vaccine capacity.
¨ Tetanus (T) is a serious illness that causes painful muscle stiffness and spasms and can lead to serious health complications, such as inability to open the mouth (lockjaw), difficulty swallowing and breathing, and can even lead to death.
¨ Diphtheria (D) is a life-threatening infection that can cause breathing problems, heart failure, paralysis, and death.